白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

已收盘 04-15 16:08:08

16.980

+0.100

+0.59%

最高17.040	最低16.910	成交量199.40万
今开17.070	昨收16.880	日振幅0.77%
总市值276.09亿	流通市值37.34亿	总股本16.26亿
成交额3,384万	换手率0.91%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":16.98,"timestamp":1776240488003,"preClose":16.88,"halted":0,"volume":1994000,"delay":0,"changeRate":0.005924170616113829,"floatShares":219900000,"shares":1626000000,"eps":2.1085960892147875,"marketStatus":"已收盘","change":0.1,"latestTime":"04-15 16:08:08","open":17.07,"high":17.04,"low":16.91,"amount":33841216,"amplitude":0.007701,"askPrice":16.98,"askSize":2000,"bidPrice":16.97,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":2.1085960892147875,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":5,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":16.88,"dividendRate":0.051631,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":1.141818,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":23,"timestamp":1776236400000,"preClose":22.86,"halted":0,"volume":9627800,"delay":0,"premium":"-35.75"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2627040731","title":"白云山最新公告：子公司王老吉大健康获重新认定为高新技术企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2627040731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627040731?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:02","pubTimestamp":1776243720,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，公司子公司广州王老吉大健康产业有限公司获重新认定为国家高新技术企业，证书发证日期为2025年12月19日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1197","BK0175","BK1191","BK0239","BK1521","BK1515","BK0012","BK0196","BK0096","BK1606","BK0097","600332","BK0028","BK0070","00874","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932411","title":"白云山：公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932411","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625932411?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:06","pubTimestamp":1775559998,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：广药白云山保障性住房还在论证中，年报中还有错别字“再”，犹犹豫豫的，是不是管理层自己都认为该项投资非必要？如有必要，有没有考虑乘房地产低迷期，直接购买现房替代？白云山（600332.SH）4月7日在投资者互动平台表示，考虑到目前房地产行业情况及各方面原因，公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604073696594532.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604073696594532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK0012","BK0196","BK0239","BK0070","BK1197","BK1515","BK1521","BK0028","00874","BK0175","600332","BK1606","BK0096","BK0188","BK0183","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625034606","title":"股市必读：白云山（600332）4月3日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2625034606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625034606?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:23","pubTimestamp":1775503389,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，白云山报收于23.03元，下跌0.56%，换手率0.77%，成交量10.79万手，成交额2.48亿元。来自机构调研要点：公司天然饮品业务推进国际化，发布国际品牌标识“WLOVI”及国际罐，并在多国上市。公司暂无回购计划，后续如有将按规定披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","00874","BK1521","BK0196","BK1606","BK0096","BK0183","BK1197","BK0012","BK0097","600332","BK0239","BK1191","BK0070","BK0188","BK0175","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625561913","title":"每周股票复盘：白云山（600332）2025年净利增5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625561913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625561913?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:12","pubTimestamp":1775329933,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，白云山报收于23.03元，较上周的22.96元上涨0.3%。本周，白云山4月2日盘中最高价报23.25元。本周关注点来自业绩披露要点：2025年归母净利润约为29.83亿元，同比增长5.21%。2025年经营活动现金流净额同比下降，主因下属企业货款回收下降，同时采购支付金额增加。2025年国内销售额70,120万元，白云山制药总厂销售收入2,274万元，研发费用约1.43万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0188","BK0012","BK0239","BK0196","BK0183","600332","BK0070","00874","BK0096","BK1191","BK1197","BK1515","BK1521","BK1606","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624947663","title":"白云山：公司已聘请第三方机构探索制定薪酬绩效优化方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2624947663","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624947663?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯，白云山在接受调研者提问时表示，公司已聘请第三方机构，结合公司实际发展需求，探索制定薪酬绩效优化方案，进一步激发人才动力，加强人才队伍建设；同时，积极探索适合公司或下属企业发展的改革方案，探索开展混改、职业经理人机制等创新性举措，同时支持符合条件的下属企业探索开展股权激励、员工持股等，进一步激发下属子公司发展活力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695294621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK1191","BK0175","BK0096","BK0097","BK0070","BK0239","BK1515","BK0188","BK1521","BK0028","BK0196","BK0183","00874","BK0012","BK1197","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624922663","title":"白云山：未来五年公司将坚持现代化、科技化、数字化、国际化发展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2624922663","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624922663?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯，白云山在接受调研者提问时表示，未来五年，公司将坚持现代化、科技化、数字化、国际化发展方向，在推动现代中药、化药科技、天然饮品、医药商业四大基石业务板块提质增效的同时，积蓄动能，培育促进消费健康、生物创新、医疗服务等业务发展，推动公司实现高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695291745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","BK0012","BK1191","BK0070","BK1515","BK1521","BK0175","BK1606","BK1197","BK0097","00874","BK0183","BK0028","BK0196","BK0239","BK0188","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655215","title":"营收微增难掩现金流“失血”：广药白云山隐现三大结构性风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655215","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655215?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:37","pubTimestamp":1775205420,"startTime":"0","endTime":"0","summary":"近日，广药集团旗下上市公司白云山发布了2025年年报。表面上看，公司实现了营收与净利润的双增长：全年营收776.56亿元，同比增长3.55%；归母净利润29.83亿元，同比增长5.21%，似乎正在从上一年的业绩低谷中缓慢修复。经营性现金流转负、高毛利业务增长乏力、研发投入萎缩，共同构成了白云山当前面临的三大结构性风险。年报披露后，公司股价的大幅下挫，正是市场对其经营质量与增长可持续性投下的“不信任票”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-03/doc-inhtferc8902395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159399","00874","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624039425","title":"小摩增持白云山(00874)约14.39万股 每股作价约16.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624039425","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624039425?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:58","pubTimestamp":1775127530,"startTime":"0","endTime":"0","summary":"3月30日，小摩增持白云山(00874)14.3924万股，每股作价16.8915港元，总金额约为243.11万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260402/20260402184617_46171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260402/20260402184617_46171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0097","LU1363072403.SGD","IE00BLSP4452.SGD","BK4588","LU2746668974.SGD","LU0006306889.USD","IE00BJTD4N35.SGD","LU2211815571.USD","BK4585","LU0208291251.USD","LU1064131342.USD","LU0943347566.SGD","LU1145028129.USD","BK0070","BK4581","LU2552382058.USD","SG9999002232.USD","LU0211327993.USD","BK0196","BK4566","LU2357305700.SGD","LU1551013342.USD","LU1917777945.USD","LU2430703251.USD","LU1629891620.HKD","LU0640476718.USD","LU0323591593.USD","LU1244550221.USD","LU2264538146.SGD","LU0203347892.USD","EWH","00874","LU1670628061.USD","IE0034235295.USD","LU0170899867.USD","BK0012","LU2237443895.HKD","LU2430703095.HKD","IE0034235303.USD","JPMO","IE000M9KFDE8.USD","BK1515","BK0239","LU0345769128.USD","LU0070302665.USD","LU2756315664.SGD","LU1084165304.USD","LU0882574139.USD","LU0238689110.USD","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597874","title":"白云山(00874)：白云山制药总厂获国家药监局核准签发关于骨化三醇软胶囊的《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597874","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624597874?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:48","pubTimestamp":1775040531,"startTime":"0","endTime":"0","summary":"2026年2月5日，白云山制药总厂向国家药监局递交药品上市持有人变更申请，于2026年3月4日获得受理。本次获得骨化三醇软胶囊的《药品补充申请批准通知书》，扩充了白云山制药总厂产品布局，有利于增强本公司在内分泌治疗药物市场的竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0070","BK1197","600332","BK1574","BK0196","01477","BK0097","BK0028","BK0183","BK0096","BK1521","00874","BK0175","BK1191","BK1515","BK0239","BK0188","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151024959","title":"白云山更新2026年3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1151024959","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151024959?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:03","pubTimestamp":1775034186,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司于2026年4月1日发布2026年3月股份变动月报表。报告期为2026年3月1日至2026年3月31日，涵盖A股和H股的发行及变动情况。报告显示，截至2026年3月底，公司注册股本共计1,625,790,949股。与上月底相比，各类股份的发行数量与库藏股数量均无变化，未有新增发行、购回或注销活动；公司并无股份期权或其他股权激励计划变动。自本次更新后，公司截至3月底的总股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621387290","title":"广药白云山晒成绩单：战略转向初见成效 2025年营利双增","url":"https://stock-news.laohu8.com/highlight/detail?id=2621387290","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621387290?lang=zh_cn&edition=full","pubTime":"2026-03-24 07:21","pubTimestamp":1774308060,"startTime":"0","endTime":"0","summary":"3月20日晚，广药集团旗下上市公司白云山（600332.SH）发布2025年年报。数据显示，白云山去年业绩实现营利双增：全年营业收入776.56亿元，同比增长3.55%；利润总额36.90亿元，同比增长2.28%；归母净利润29.83亿元，同比增长5.21%。值得注意的是，2025年是李小军履新广药集团董事长后全面掌舵的一年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603243681438361.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603243681438361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","BK0183","BK0070","BK0239","BK1515","BK0097","BK0196","BK1197","600332","BK1191","BK1606","BK1521","BK0012","BK0188","BK0175","00874","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621869150","title":"股市必读：白云山（600332）3月23日收盘跌8%，主力净流出911.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621869150","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621869150?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:40","pubTimestamp":1774291223,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，白云山报收于23.11元，下跌8.0%，换手率2.96%，成交量41.68万手，成交额9.76亿元。交易信息汇总3月23日白云山收盘报23.11元，跌8%，当日成交4167.83万元。该股已连续4日下跌。前10个交易日主力资金累计净流出7625.6万元，股价累计下跌8.14%；融资余额累计减少5699.42万元，融券余量累计减少5.11万股。当日资金流向方面，主力资金净流出911.21万元，占总成交额0.93%；游资资金净流入3415.88万元，占总成交额3.5%；散户资金净流出2504.66万元，占总成交额2.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK1521","BK0096","BK1606","BK0097","BK0196","BK0239","BK0175","BK1197","BK0070","600332","BK0012","BK1515","00874","BK0183","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199362268","title":"异动解读 | 白云山盘中大跌5.07%，因年报显示第四季度净利润下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1199362268","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199362268?lang=zh_cn&edition=full","pubTime":"2026-03-23 09:33","pubTimestamp":1774229589,"startTime":"0","endTime":"0","summary":"白云山（00874）今日盘中股价大幅下挫5.07%，市场关注度显著提升。消息面上，公司于盘前发布了2025年年度报告。报告显示，尽管全年归母净利润实现同比增长，但第四季度单季归母净利润为-3.27亿元，同比下降1.07%。这一关键财务数据的表现不及预期，引发了投资者对公司短期盈利能力的担忧，可能是导致股价承压下跌的主要原因。此外，年报还披露了公司的利润分配方案，拟向全体股东每股派发现金红利0.45元（含税），并计划于中期实施现金分红。公司董事会亦审议通过了多项议案，包括向金融机构申请综合授信额度等。大信会计师事务所对公司的财务报告出具了标准无保留意见审计报告。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621719165","title":"白云山拟每股派发现金红利0.45元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621719165","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621719165?lang=zh_cn&edition=full","pubTime":"2026-03-22 16:03","pubTimestamp":1774166580,"startTime":"0","endTime":"0","summary":"3月20日，白云山（600332/00874）发布公告，公司拟向全体股东每股派发现金红利0.45元（含税），预计总派发金额为7.32亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679731212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600332","BK1606","BK0070","BK0028","BK0097","BK1197","BK0188","BK0196","BK0096","BK1515","BK1521","BK0183","BK0175","BK0239","00874","BK1191","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621947257","title":"白云山（600332）2025年年报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2621947257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621947257?lang=zh_cn&edition=full","pubTime":"2026-03-22 06:01","pubTimestamp":1774130467,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期白云山发布2025年年报。根据财报显示，白云山营收净利润同比双双增长。截至本报告期末，公司营业总收入776.56亿元，同比上升3.55%，归母净利润29.83亿元，同比上升5.21%。按单季度数据看，第四季度营业总收入160.5亿元，同比上升0.74%，第四季度归母净利润-3.27亿元，同比下降1.07%。该数据低于大多数分析师的预期，此前分析师普遍预期2025年净利润为盈利37.35亿元左右。本次财报公布的各项数据指标表现一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796258","title":"每周股票复盘：白云山（600332）2025年净利增5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796258?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:17","pubTimestamp":1774117030,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，白云山报收于25.12元，较上周的25.46元下跌1.34%。本周，白云山3月17日盘中最高价报25.76元。本周关注点来自业绩披露要点：白云山2025年归母净利润29.83亿元，同比上升5.21%。股本股东变化截至2026年2月28日，白云山股东户数为10.09万户，较2025年12月31日增加6220户，增幅6.57%。大信会计师事务所审核确认，公司2025年度控股股东及其他关联方资金占用情况公允反映于汇总表中，未发现违规占用情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0183","BK0012","BK0070","BK1521","00874","BK0097","BK0196","BK0188","600332","BK0239","BK1515","BK1606","BK0096","BK1191","BK0028","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620732936","title":"白云山(00874)发布年度业绩，归母净利润29.83亿元 同比增加5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732936","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620732936?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:29","pubTimestamp":1774016940,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山 发布截至2025年12月31日止年度业绩，该集团取得营业收入776.56亿元，同比增加3.55%;归属于本公司股东的净利润29.83亿元，同比增加5.21%;基本每股收益1.835元，拟派发每股现金红利0.45元。2025年，本集团紧紧围绕生物医药健康的战略定位，依托产业优势，充分挖掘自身资源与资产，全面推进生产经营各项工作，推动业务持续稳定增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00874","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620326037","title":"白云山(00874)将派发末期股息每股0.45元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620326037","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620326037?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:28","pubTimestamp":1774016936,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，将派发截至2025年12月31日止年度的末期股息每股0.45元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK4588","BK4585","BK0097","BK1521","600332","BK0096","BK0070","BK0175","BK0183","BK0196","BK0239","BK1197","00874","BK0188","BK1191","BK1515","VIG","BK0028","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620241656","title":"港股公告掘金 | 蚂蚁集团收购耀才证券金融的要约已获批准 3月17日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2620241656","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620241656?lang=zh_cn&edition=full","pubTime":"2026-03-17 09:04","pubTimestamp":1773709477,"startTime":"0","endTime":"0","summary":"重大事项：恒瑞医药(01276)：SHR-1819注射液、SHR-1905注射液获得药物临床试验批准通知书复宏汉霖(02696)：PIMURUTAMAB HLX07联合汉斯状和化疗治疗晚期鳞状非小细胞肺癌的临床试验申请获国家药监局批准白云山(00874)：虚汗停颗粒用于儿童反复呼吸道感染的临床试验申请获批派格生物医药-B(02565)与腾瑞制药达成派达康中国大陆独家商业化合作 商业化目标累计销售规","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"808c1f0b8ebd0042a82fe4057566a434","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1023057109.AUD","02565","HK0000306685.HKD","01276","BK1606","LU0359201885.HKD","BK1191","BK1147","BK4585","HK0000306701.USD","BK1161","HK0000320223.HKD","LU2543165471.USD","BK1515","01428","LU0359201612.USD","VXUS","HK0000320264.USD","LU0359202008.SGD","02696","BK1197","HK0000165453.HKD","06688","00874","BK1521","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619345179","title":"白云山(00874)：广州医药应收账款资产支持专项计划资产支持证券挂牌转让获得上交所无异议函","url":"https://stock-news.laohu8.com/highlight/detail?id=2619345179","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619345179?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:27","pubTimestamp":1773656854,"startTime":"0","endTime":"0","summary":"白云山(00874)发布公告，2026 年 3 月 13 \n日，本公司收到兴证证券资产管理有限公司(“兴证资管”)转发的上海证券交易所(“上交所”)《关于对兴证圆融-广州医药应收账款 5-9 \n期资产支持专项计划资产支持证券挂牌转让无异议的函》(上证函[2026]830 号)(“《无异议函》”)，现将相关情况公告如下：","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09939","159938","161027","BK1191","BK0028","BK0239","BK1521","BK1515","BK1574","BK0097","BK1606","BK1161","BK1197","600332","BK0183","00874","BK0188","BK0175","BK0012","BK0196","BK0096","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":-0.1026},{"period":"3month","weight":-0.0964},{"period":"6month","weight":-0.0684},{"period":"1year","weight":0.056},{"period":"ytd","weight":-0.0474}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.208},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009902},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058504},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049388},{"month":4,"riseRate":0.655172,"avgChangeRate":0.082285},{"month":5,"riseRate":0.571429,"avgChangeRate":0.048693},{"month":6,"riseRate":0.5,"avgChangeRate":0.021373},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.016161},{"month":8,"riseRate":0.392857,"avgChangeRate":-0.036785},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.010651},{"month":10,"riseRate":0.428571,"avgChangeRate":0.003937},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008347},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023788}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}